We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$4.86M
Cap. Flow
-$11.9M
Cap. Flow %
-10.02%
Top 10 Hldgs %
38.75%
Holding
162
New
35
Increased
26
Reduced
36
Closed
51

Sector Composition

Rank Sector Weight
1 Energy 35.96%
2 Healthcare 23.86%
3 Technology 9.66%
4 Industrials 7.96%
5 Financials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
1
Alaunos Therapeutics
TCRT
$4.74M
$10.4M 8.74%
15,133
-1,967
-12% -$1.32M
RNET
2
DELISTED
RigNet, Inc.
RNET
$9.15M 7.69%
170,000
+19,000
+13% +$917K
HALO icon
3
Halozyme
HALO
$9.72B
$4.45M 3.74%
350,500
+8,500
+2% +$126K
MMP
4
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4.31M 3.62%
61,768
-9,800
-14% -$652K
ET icon
5
Energy Transfer Partners
ET
$70.1B
$4.03M 3.39%
172,400
-21,160
-11% -$457K
EPD icon
6
Enterprise Products Partners
EPD
$83.8B
$3.97M 3.34%
114,560
-18,474
-14% -$612K
WWAV
7
DELISTED
The WhiteWave Foods Company
WWAV
$2.48M 2.09%
87,000
+63,000
+263% +$1.67M
FCSC
8
DELISTED
Fibrocell Science Inc.
FCSC
$2.46M 2.07%
31,313
+14,646
+88% +$1.14M
PAA icon
9
Plains All American Pipeline
PAA
$17.4B
$2.42M 2.04%
44,000
-8,105
-16% -$425K
META icon
10
Meta Platforms (Facebook)
META
$1.51T
$2.42M 2.04%
40,200
+14,000
+53% +$887K
BPL
11
DELISTED
Buckeye Partners, L.P.
BPL
$2.42M 2.03%
32,260
-4,868
-13% -$353K
HTH icon
12
Hilltop Holdings
HTH
$2.29B
$2.38M 2%
100,000
+35,000
+54% +$832K
GNMX
13
DELISTED
Aevi Genomic Medicine Inc
GNMX
$2.37M 1.99%
340,000
+10,000
+3% +$78.1K
OKE icon
14
Oneok
OKE
$58.7B
$2.19M 1.84%
37,000
-9,488
-20% -$555K
CEMP
15
DELISTED
Cempra, Inc.
CEMP
$2.1M 1.77%
182,000
+22,000
+14% +$274K
LJPC
16
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2M 1.68%
+185,000
New +$1.82M
KKR icon
17
KKR & Co
KKR
$89.2B
$1.78M 1.49%
77,800
-6,950
-8% -$168K
WMB icon
18
Williams Companies
WMB
$90.5B
$1.75M 1.47%
43,000
+900
+2% +$36.5K
PNR icon
19
Pentair
PNR
$10.2B
$1.71M 1.43%
32,014
+3,351
+12% +$175K
LNG icon
20
Cheniere Energy
LNG
$56.5B
$1.66M 1.4%
30,000
+10,000
+50% +$479K
EPB
21
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$1.43M 1.2%
47,170
-11,870
-20% -$377K
RGP
22
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$1.37M 1.15%
50,168
-5,332
-10% -$143K
SGYP
23
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.33M 1.12%
250,000
-3,500
-1% -$19.6K
WES icon
24
Western Midstream Partners
WES
$19.6B
$1.3M 1.09%
26,500
MWE
25
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
$1.24M 1.04%
19,000
-2,400
-11% -$162K

Similar funds

Belmont Global Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Belmont Global Advisors held 162 positions worth $119M, down 3.9% from $124M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Belmont Global Advisors withdrew a net $11.9M in Q1 2014, closing 51 positions and reducing 36 holdings. Its most notable exit was Icahn Enterprises, an estimated $2.69M position sold in full.

By sector, the portfolio is most concentrated in Energy at 36% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Belmont Global Advisors opened a new position in La Jolla Pharmaceutical Company worth $2M.

  • Belmont Global Advisors's largest Q1 2014 buy was La Jolla Pharmaceutical Company: 185,000 shares worth $2M.
  • Belmont Global Advisors added most to The WhiteWave Foods Company in Q1 2014, an estimated $1.67M increase.
  • Belmont Global Advisors's biggest Q1 2014 reduction was Theriva Biologics, cutting an estimated $2.73M.
  • Belmont Global Advisors fully exited Icahn Enterprises in Q1 2014, selling an estimated $2.69M.
  • Belmont Global Advisors's ten largest holdings make up 39% of its $119M portfolio in Q1 2014.
  • Belmont Global Advisors opened 35 new positions and closed 51 in Q1 2014.
  • Belmont Global Advisors's portfolio value fell 3.9% quarter-over-quarter to $119M.

Based on Belmont Global Advisors's 13F filing for Q1 2014, filed 13 May 2014.